LONDON--(BUSINESS WIRE)--Advancements in technology, customers’ changing expectations, and increasing investment in the healthcare industry have influenced significant growth in the in-vitro ...
Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Report 2025" has been added to ResearchAndMarkets.com's offering. The artificial ...
While much of the focus around in vitro diagnostics has lately been around their utility in the fight against the COVID-19 global pandemic, there is much more going on with IVDs in multiple disease ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Proxim Diagnostics Corp., an innovative company developing a handheld, point-of care diagnostic device, announced it has received a strategic investment from ...
The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.
This article is the third in Microbiologics’ series on Optimal QC in the Clinical Laboratory. Previously, in this series we highlighted the importance of external and third-party quality control ...
DELRAY BEACH, Fla., Dec. 15, 2025 /PRNewswire/ -- According to MarketsandMarkets™, the US In Vitro Diagnostics Market is projected to grow from about USD 37.43 Billion in 2025 to USD 57.18 billion by ...
In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first ...
Research assistant Nicole Gebert contributed to this article. Part 1 of this article discussed the background and purpose of the EU In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR), the definition ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 ...
According to MarketsandMarkets, the US In Vitro Diagnostics Market is projected to grow from about USD 37.43 Billion in 2025 to USD 57.18 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results